Literature DB >> 7289231

Relationship between hemodynamics and cardiac metabolism in the reperfusion period following hypothermic global ischemia.

M Sunamori, J Amano, A Suzuki.   

Abstract

Ten mongrel dogs were subjected to hypothermic ischemic cardioplegia for two hours followed by 30 minutes of reperfusion to characterize the relationship between hemodynamic parameters during reperfusion and the recovery of high energy store of the post-ischemic left ventricular myocardium. Dogs were anesthetized with intravenous pentobarbital 30 mg/kg, and standard cardiopulmonary bypass was instituted with the flow rate of 80 ml/min/kg and perfusion pressure around 80 mmHg. Ischemic cardioplegia was obtained by cross-clamping of the aorta for 2 hours under 20 degrees C of myocardial temperature. After termination of cardioplegia, the heart was rewarmed by the support of cardiopulmonary bypass with the flow rate of 80 ml/min/kg until the myocardial temperature was reached 36 degrees C. Hemodynamic parameters were measured throughout the experiment and myocardial adenosine triphosphate (ATP) and creatine phosphate (CP) were measured at the end of experiment. Correlation was significant between myocardial ATP and coronary blood flow and myocardial oxygen consumption. However, myocardial creatine phosphate correlated poorly to coronary blood flow, myocardial oxygen consumption and other hemodynamic parameters. These results indicate that the recovery of myocardial high energy store is partly related to coronary blood flow and myocardial oxygen consumption, but other parameters are probably involved in the process of early recovery of the myocardium from ischemic cardioplegia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7289231     DOI: 10.1007/BF02468763

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  24 in total

1.  Calcium paradox: changes in high-energy phosphate compounds of isolated perfused rat hearts.

Authors:  A B Boink; T J Ruigrok; A H Maas; A N Zimmerman
Journal:  Recent Adv Stud Cardiac Struct Metab       Date:  1976 May 26-29

2.  Influence of ATP or oxygen plus substrate on occurrence of the calcium paradox.

Authors:  T J Ruigrok; A B Boink; A N Zimmerman
Journal:  Recent Adv Stud Cardiac Struct Metab       Date:  1976 May 26-29

3.  Coronary driving pressure and vasomotor tonus as determinants of coronary blood flow.

Authors:  C E CROSS; P A RIEBEN; P F SALISBURY
Journal:  Circ Res       Date:  1961-05       Impact factor: 17.367

4.  Ventricular fibrillation in dogs after sudden return of flow to the coronary artery.

Authors:  W H SEWELL; D R KOTH; C E HUGGINS
Journal:  Surgery       Date:  1955-12       Impact factor: 3.982

5.  Hemodynamic determinants of coronary flow: effect of changes in aortic pressure and cardiac output on the relationship between myocardial oxygen consumption and coronary flow.

Authors:  E Braunwald; S J Sarnoff; R B Case; W N Stainsby; G H Welch
Journal:  Am J Physiol       Date:  1958-01

6.  The effect of acute coronary artery occlusion on subepicardial transmembrane potentials in the intact porcine heart.

Authors:  E Downar; M J Janse; D Durrer
Journal:  Circulation       Date:  1977-08       Impact factor: 29.690

7.  Myocardial potassium and ventricular arrhythmias following reperfusion of ischaemic myocardium.

Authors:  R R Taylor
Journal:  Aust N Z J Med       Date:  1971-05

8.  Studies on myocardial reperfusion injury. I. Favorable modification by adjusting reperfusate pH.

Authors:  D Follette; K Fey; J Livesay; J V Maloney; G D Buckberg
Journal:  Surgery       Date:  1977-07       Impact factor: 3.982

9.  Myocardial damage after repetitive direct current shock in the dog: correlation between left ventricular end-diastolic pressure and extent of myocardial necrosis.

Authors:  J Mehta; W Runge; J N Cohn; P Carlyle
Journal:  J Lab Clin Med       Date:  1978-02

10.  Contractile damage from reperfusion after transient ischemia in the dog.

Authors:  H J Smith; K M Kent; S E Epstein
Journal:  J Thorac Cardiovasc Surg       Date:  1978-03       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.